Overview

Webcast ImageWebcast
Q2 2016 Laboratory Corporation of America Holdings Earnings Conference Call (Live)
07/27/16 at 9:00 a.m. ET
Corporate Profile

Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue pro... More >>

Recent NewsMore >>
DateTitle 
07/01/16Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
BURLINGTON, N.C.--(BUSINESS WIRE)--Jul. 1, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject to the terms of the Zero Coupon Notes and the Indenture, dated as of October 24, 2006 between LabCorp and T... 
Printer Friendly Version
06/27/16LabCorp Announces Launch of New Companion Diagnostic for Non-Small Cell Lung Cancer
The Roche cobas® EGFR Mutation Test v2 is the First Blood-Based Liquid Biopsy Test Approved by FDA for Clinical Use BURLINGTON, N.C.--(BUSINESS WIRE)--Jun. 27, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the availability of a new application for the companion diagnostic associated with the use of Tarceva® for the treatment of certain patients with non-small cell lung cancer (NSCLC). The Roche... 
Printer Friendly Version
06/08/16LabCorp is Scheduled to Present at the 36th Annual William Blair Growth Stock Conference
BURLINGTON, N.C.--(BUSINESS WIRE)--Jun. 8, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced it will participate at the 36th Annual William Blair Growth Stock Conference. LabCorp’s presentation is planned for Tuesday, June 14, 2016 at 3:50 PM (ET). A live audio webcast of the presentation will be available via the Company website at www.labcorp.com and archived for replay. About LabCorp... 
Printer Friendly Version
06/06/16LabCorp Announces the Availability of the RealStar® Zika Virus Test
altona Diagnostics’ RealStar® Zika Virus RT-PCR Kit U.S. Has Received FDA Emergency Use Authorization BURLINGTON, N.C.--(BUSINESS WIRE)--Jun. 6, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) today announced the nationwide availability of testing for Zika virus using the RealStar® Zika Virus RT-PCR Kit U.S. from altona Diagnostics GmbH. The test has received Emergency Use Authorization (EUA) from the U.S. Food and Drug... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
07/27/16
Q2 2016 Laboratory Corporation of America Holdings Earnings Conference Call
LH (Common)
ExchangeNYSE
Price$138.82
Change Stock is Up 0.94
Intraday High$138.98
Intraday Low$138.11
Volume513,195
Data as of 07/22/16
4:02 p.m. ET
Minimum 20 minute delay
Refresh quote

Reports & Performance

2014 Annual Report

2013 Annual Report

2012 Annual Report

2011 Annual Report

2010 Annual Report

2009 Annual Report

2008 Annual Report

2007 Annual Report

2006 Annual Report

Latest Earnings Release